Annual CFF
-$41.00 K
+$500.00+1.20%
31 December 2023
Summary:
Cardiol Therapeutics annual cash flow from financing activities is currently -$41.00 thousand, with the most recent change of +$500.00 (+1.20%) on 31 December 2023. During the last 3 years, it has fallen by -$12.20 million (-100.34%). CRDL annual CFF is now -100.06% below its all-time high of $74.53 million, reached on 31 December 2021.CRDL Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$3000.00
-$59.20 K-105.34%
30 September 2024
Summary:
Cardiol Therapeutics quarterly cash flow from financing activities is currently -$3000.00, with the most recent change of -$59.20 thousand (-105.34%) on 30 September 2024. Over the past year, it has increased by +$7400.00 (+71.15%). CRDL quarterly CFF is now -100.01% below its all-time high of $47.39 million, reached on 01 December 2021.CRDL Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$99.70 K
+$7400.00+8.02%
30 September 2024
Summary:
Cardiol Therapeutics TTM cash flow from financing activities is currently $99.70 thousand, with the most recent change of +$7400.00 (+8.02%) on 30 September 2024. Over the past year, it has increased by +$141.50 thousand (+338.52%). CRDL TTM CFF is now -99.87% below its all-time high of $74.53 million, reached on 01 December 2021.CRDL TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRDL Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.2% | +71.2% | +338.5% |
| 3 y3 years | -100.3% | -100.3% | -99.6% |
| 5 y5 years | -100.2% | -121.7% | -99.2% |
CRDL Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -100.1% | +1.2% | -100.0% | +72.2% | -99.9% | +338.5% |
| 5 y | 5 years | -100.1% | +1.2% | -100.0% | +81.6% | -99.9% | +338.5% |
| alltime | all time | -100.1% | +1.2% | -100.0% | +81.6% | -99.9% | +338.5% |
Cardiol Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3000.00(-105.3%) | $99.70 K(+8.0%) |
| June 2024 | - | $56.20 K(-0.7%) | $92.30 K(+259.1%) |
| Mar 2024 | - | $56.60 K(-660.4%) | $25.70 K(-162.5%) |
| Dec 2023 | -$41.00 K(-1.2%) | -$10.10 K(-2.9%) | -$41.10 K(-1.7%) |
| Sept 2023 | - | -$10.40 K(0.0%) | -$41.80 K(+0.5%) |
| June 2023 | - | -$10.40 K(+2.0%) | -$41.60 K(+0.2%) |
| Mar 2023 | - | -$10.20 K(-5.6%) | -$41.50 K(0.0%) |
| Dec 2022 | -$41.50 K(-100.1%) | -$10.80 K(+5.9%) | -$41.50 K(-100.1%) |
| Sept 2022 | - | -$10.20 K(-1.0%) | $47.36 M(-2.5%) |
| June 2022 | - | -$10.30 K(+1.0%) | $48.57 M(-26.2%) |
| Mar 2022 | - | -$10.20 K(-100.0%) | $65.79 M(-11.7%) |
| Dec 2021 | $74.53 M | - | - |
| Dec 2021 | - | $47.39 M(+3833.2%) | $74.53 M(+174.6%) |
| Sept 2021 | - | $1.20 M(-93.0%) | $27.14 M(+2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | $17.21 M(+97.1%) | $26.47 M(+26.7%) |
| Mar 2021 | - | $8.73 M(<-9900.0%) | $20.90 M(+71.8%) |
| Dec 2020 | $12.16 M(+695.5%) | -$4300.00(-100.8%) | $12.16 M(+0.1%) |
| Sept 2020 | - | $543.70 K(-95.3%) | $12.15 M(+4.6%) |
| June 2020 | - | $11.63 M(<-9900.0%) | $11.62 M(+3813.8%) |
| Mar 2020 | - | -$9000.00(-44.8%) | $296.90 K(-80.6%) |
| Dec 2019 | $1.53 M(-92.2%) | -$16.30 K(-218.1%) | $1.53 M(-87.3%) |
| Sept 2019 | - | $13.80 K(-95.5%) | $12.05 M(-10.6%) |
| June 2019 | - | $308.40 K(-74.8%) | $13.48 M(-35.0%) |
| Mar 2019 | - | $1.22 M(-88.4%) | $20.73 M(+6.3%) |
| Dec 2018 | $19.51 M(+587.5%) | $10.50 M(+627.3%) | $19.51 M(+116.6%) |
| Sept 2018 | - | $1.44 M(-80.9%) | $9.01 M(+19.1%) |
| June 2018 | - | $7.56 M(>+9900.0%) | $7.56 M(>+9900.0%) |
| Mar 2018 | - | $0.00 | $0.00 |
| Dec 2017 | $2.84 M | - | - |
FAQ
- What is Cardiol Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Cardiol Therapeutics?
- What is Cardiol Therapeutics annual CFF year-on-year change?
- What is Cardiol Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Cardiol Therapeutics?
- What is Cardiol Therapeutics quarterly CFF year-on-year change?
- What is Cardiol Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Cardiol Therapeutics?
- What is Cardiol Therapeutics TTM CFF year-on-year change?
What is Cardiol Therapeutics annual cash flow from financing activities?
The current annual CFF of CRDL is -$41.00 K
What is the all time high annual CFF for Cardiol Therapeutics?
Cardiol Therapeutics all-time high annual cash flow from financing activities is $74.53 M
What is Cardiol Therapeutics annual CFF year-on-year change?
Over the past year, CRDL annual cash flow from financing activities has changed by +$500.00 (+1.20%)
What is Cardiol Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of CRDL is -$3000.00
What is the all time high quarterly CFF for Cardiol Therapeutics?
Cardiol Therapeutics all-time high quarterly cash flow from financing activities is $47.39 M
What is Cardiol Therapeutics quarterly CFF year-on-year change?
Over the past year, CRDL quarterly cash flow from financing activities has changed by +$7400.00 (+71.15%)
What is Cardiol Therapeutics TTM cash flow from financing activities?
The current TTM CFF of CRDL is $99.70 K
What is the all time high TTM CFF for Cardiol Therapeutics?
Cardiol Therapeutics all-time high TTM cash flow from financing activities is $74.53 M
What is Cardiol Therapeutics TTM CFF year-on-year change?
Over the past year, CRDL TTM cash flow from financing activities has changed by +$141.50 K (+338.52%)